News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
116 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19233)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (1709)
Day
1 (121)
2 (97)
3 (8)
5 (6)
6 (79)
7 (151)
8 (89)
9 (80)
10 (30)
13 (139)
14 (106)
15 (102)
16 (135)
17 (48)
19 (25)
20 (84)
21 (88)
22 (116)
23 (109)
24 (78)
26 (6)
27 (12)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
Day
1
2
3
5
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
26
27
Artificial intelligence
AI data becomes sticking point in biopharma dealmaking
As drug hunting gets more complex, where and how data is generated in partnerships between Big Pharmas and AI biotechs is becoming a headache for dealmakers.
July 22, 2026
·
2 min read
·
Annalee Armstrong
Business
Wainua flop narrows AstraZeneca’s path to $80B goal ahead of high-risk readouts
With a Phase 3 failure denting the rare disease drug’s prospects, AstraZeneca has little room for error as it plots a path toward its ambitious 2030 sales target.
July 22, 2026
·
4 min read
·
Nick Paul Taylor
Career Advice
From Big Pharma to specialty: why moving closer to the patient changes everything
Working at a Big Pharma has its benefits, but there are limitations too. SERB Pharmaceuticals’ Thomas Kolaras discusses how moving to a midsize company creates new opportunities for sharpened thinking and leadership.
July 22, 2026
·
6 min read
·
Thomas Kolaras
IPO
2026 IPO stock tracker: How newly public biotechs are performing
BioSpace
is launching an IPO dashboard to help the industry keep tabs on U.S. biotechs that have taken the public plunge in 2026.
July 22, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Mercury Medical Awarded Respiratory Therapy, Resuscitation Devices Agreement with Premier, Inc.
July 22, 2026
·
2 min read
Press Releases
Citius Oncology Reports Nationwide Deployment of LYMPHIR’s Broadened Commercial Organization and Expanding Market Adoption
July 22, 2026
·
14 min read
Press Releases
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions
July 22, 2026
·
5 min read
Press Releases
i-Lumen Scientific Announces First U.S. Patient Randomized in i-SIGHT2 Pivotal Study Evaluating Noninvasive Bioelectric Therapy for Intermediate to Advanced Dry AMD
July 22, 2026
·
4 min read
Press Releases
FUJIFILM Sonosite Expands Portfolio with the Launch of Sonosite iLOOK, a Dedicated Ultrasound Solution for Vascular Access
July 22, 2026
·
3 min read
Press Releases
Clinicians Report That Summit 2.0™ Influenced Clinical Decision-Making in 86% of Cases; 96% Stated They Would Order the Test Again
July 22, 2026
·
2 min read
1 of 12
Next
